Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy With or Without Carboplatin in Elderly Patients With Locally Advanced NSCLC
NCT00132665Phase 3Completed
- Sponsor
- Japan Clinical Oncology Group
- Start
- Jul 2003
- Primary completion
- Nov 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of carboplatin in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Japan Clinical Oncology Group. Primary endpoint: Overall survival. Started Jul 2003; status: completed.
02
Drugs
carboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00132665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132665.